06 dec: 29% fortryder efterløn
09 dec: Skandalen ingen taler om
06-12-2010 19:17:00

Bloomberg plans to build new European HQ in London

Relateret indhold

LONDON (Reuters) - Global news agency and media group Bloomberg said a new European headquarters designed by Norman Foaster and set to be built on a site near the Bank of England should be completed in 2015.

U.S.-based property developer Tishman Speyer will be development manager on the project -- two buildings on a 3.2-acre site close to Bloomberg's existing European HQ.

The Financial Times reported Bloomberg had signed a deal to buy the site from Legal and General (Legal & General Group PLC ORD).

When completed, Bloomberg will occupy one of the 500,000 square feet office blocks, while the second will be a "speculative building," it said. Speculative buildings are those for which no occupants have been identified.

A Bloomberg spokeswoman declined to comment on the sum paid for the new site, and said it has yet to make plans for the second building, or for the company's existing London offices near Moorgate.

Bloomberg's current London headquarters on Finsbury Square, part of which was also designed by Foster, has served as the company's European headquarters since 1987 and currently houses over 2,300 employees, it said.

Major developers including British Land (British Land Company PLC ORD 2), Hammerson (Hammerson PLC ORD 25P) and Land Securities (Land Securities Group PLC) have unveiled plans to build new office buildings in London in recent months, stirring industry concerns of a potential oversupply as Britain's economic recovery remains weak.

(Reporting by Daryl Loo; Editing by Dan Lalor)

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Maersk Line-chef tager på charmeoffensiv i Kina

19-09-2014 15:47:03
Den administrerende direktør for Maersk Line, Søren Skou, har besøgt de kinesiske myndigheder i et forsøg på at skaffe opbakning til en ny shipping-alliance med..

Novo/Sydbank: Novo sidder tungt på diabetes-tronen

19-09-2014 12:17:21
Sydbank fastholder sin anbefaling af Novo Nordisk-aktien til trods for, at den amerikanske lægemiddelstyrelse, FDA, torsdag aften har godkendt Novo-konkurrenten..

Novo: Nygodkendt diabetesmiddel giver lynhurtigt effekt

19-09-2014 11:31:02
Novo Nordisks nye kombinationspræparat til behandling af type 2 diabetes, Xultophy, yder allerede efter fire uger en betydelig blodsukkerkontrol.Det fremgår af ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/Jyske: Svagt momentum bag lavere kursmål
2
Aktier/åbning: C20 styrer mod rekord efter skotsk afstemning
3
Novo får godkendt kombinationsmidlet Ideglira i EU
4
Aktier/tendens: Skotsk afstemning løfter stemningen
5
Aktier/middag: Skotterne sender Vestas og C20 til vejrs

Relaterede aktiekurser

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Relaterede selskaber
Få adgang til information og anbefalinger af relaterede selskaber med PLUS pakken.

Du får adgang til 7 værdifulde investorværktøjer til investering.

Klik her og læs mere om PLUS pakken.
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
19. september 2014 17:51:35
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140919.1 - EUROWEB3 - 2014-09-19 17:51:35 - 2014-09-19 17:51:35 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x